+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
FEMALE
ID05953090

Study of a Non-Hormonal Gel for Treating Vulvovaginal Skin Conditions in Adult Women

Led by Stratpharma AG · Updated on 2026-02-20

2000

Participants Needed

14

Research Sites

26 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying vulvovaginal skin conditions such as vaginal atrophy, lichen sclerosus, lichen simplex chronicus, and lichen planus in adult women. The study aims to evaluate the short- and long-term safety and effectiveness of a new gel dressing device designed to support vulvovaginal mucosal health and promote recovery after vaginal rejuvenation. The investigational treatment being assessed is a non-hormonal, non-steroidal gel called 7-0940. This gel is intended to relieve symptoms like itchiness, dryness, burning, painful intercourse, and tenderness while improving skin conditions such as erythema and tissue thinning. The gel supports a moist healing environment to speed up tissue repair and is intended for long-term use without the side effects associated with hormonal or corticosteroid therapies. Participants will be observed over a 12-month period where researchers will measure changes in symptom scores, quality of life, and clinical signs using questionnaires and rating scales. Safety will be monitored by tracking adverse reactions and treatment adherence. The study involves using digital devices like smartphones or computers for communication and data collection. Total participation duration and detailed assessments are planned to understand the gels impact on vulvovaginal health over time.

CONDITIONS

Brief Title

VALOR: Vaginal Atrophy & Long-term Observation of Recovery

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here